Trends and Key Areas of Research in the Pathophysiology, Imaging, and Treatment of Type 3 Macular Neovascularization (MNV3) Associated with Age-Related Macular Degeneration (AMD) - Summary - MDSpire
Advertisement
Trends and Key Areas of Research in the Pathophysiology, Imaging, and Treatment of Type 3 Macular Neovascularization (MNV3) Associated with Age-Related Macular Degeneration (AMD)
To provide an overview of the research hotspots and directions of type 3 macular neovascularization (MNV3) in age-related macular degeneration specifically through bibliometric analysis.
Approach:
Key Findings:
The United States leads in MNV3 research output from 2001 to 2026.
Kim JW is the most prolific author; Yannuzzi LA is the most cited.
High-frequency keywords include 'ranibizumab', 'photodynamic therapy', and 'optical coherence tomography'.
Emerging research hotspots involve 'artificial intelligence', 'biomarker', and 'microglia'.
Research topics are categorized into pathogenesis, imaging, therapy, and clinical prognosis.
Interpretation:
The analysis highlights significant advancements and collaborative efforts in MNV3 research, indicating a growing interest and evolving understanding of the condition, which may guide future research directions.
Limitations:
The study is limited to publications in English, which may introduce language bias.
Only two databases were used for literature retrieval.
Conclusion:
This bibliometric analysis elucidates research hotspots and directions in MNV3, providing a foundation for future investigations in this evolving field.
Two doctors have developed a groundbreaking wearable vision aid using AI technology to help individuals with low vision navigate daily activities, offering features such as a multimedia AI-powered assistant and lightweight, intuitive design.
Terry Kim, MD, discusses his roles as CMO and head of global medical safety at Alcon, why and how he moved in this direction with his career, the Unity Vitreoretinal Cataract and Unity Cataract Systems, and more.
